Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Developments on antibiotics for multidrug resistant bacterial Gram-negative infections

20 Apr 2019

Abstract excerpt

Introduction: The constantly increasing spread of severe infections due to multidrug-resistant (MDR) Gram-negative bacteria (GNB) is a critical threat to the global medical community. After a long period of antibiotic pipeline pause, new antibiotic compounds are commercially available or are at late stages of clinical evaluation, promising to augment the therapeutic armamentarium of clinicians against deadly...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibiotic Resistance in Bacteria
Share to Antibiotics Pharmacokinetics and Efficacy
Share to Urinary Tract Infections Management

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31006284
DOI: 10.1080/14787210.2019.1610392

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 18 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Developments on antibiotics for multidrug resistant bacterial Gram-negative infectionsPMID 31006284Read ↗

The antibiotic pipeline for multi-drug resistant gram negative bacteria: what can we expect?Semantic proximity Read ↗

Combating multidrug-resistant Gram-negative bacterial infectionsSemantic proximity Read ↗

Current and future perspectives in the treatment of multidrug-resistant Gram-negative infectionsSemantic proximity Read ↗

New β-lactam antibiotics and β-lactamase inhibitorsSemantic proximity Read ↗

Resistance of Gram-Positive Bacteria to Current Antibacterial Agents and Overcoming ApproachesSemantic proximity Read ↗

Mechanisms of Antibiotic Resistance in Important Gram-Positive and Gram-Negative Pathogens and Novel Antibiotic SolutionsSemantic proximity Read ↗

Beta-lactams and Beta-lactamase-inhibitors in current- or potential-clinical practice: A comprehensive updateSemantic proximity Read ↗

Resistance to beta-lactams in Gram-negative bacilli: relevance and potential therapeutic alternativesSemantic proximity Read ↗

Old and New Beta-Lactamase Inhibitors: Molecular Structure, Mechanism of Action, and Clinical UseSemantic proximity Read ↗

Treatment of Infections Due to MDR Gram-Negative BacteriaSemantic proximity Read ↗

Antibiotics and Bacterial Resistance—A Short Story of an Endless Arms RaceSemantic proximity Read ↗

Development of Antimicrobial Agents in the Era of New and Reemerging Infectious Diseases and Increasing Antibiotic ResistanceSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.